65,437 trials
Influenza
Primary: Number of Participants Reporting Solicited Local Reactions Based on the Functional Grading Scale After the First Vaccination — 29; 53; 62; 95 Participants
Breast Cancer
Primary: Number of Participants With Delivery of 34 Gy in 10 Fractions — 42 Participants
Pulmonary Disease, Chronic Obstructive
Primary: Number of Participants Having a Hospitalization or Emergency Room (ER) Visit Related to Chronic Obstructive Pulmonary Disease (COPD) Represented Per 100 Person-years…
Nocturia Associated With Nocturnal Polyuria
Primary: Overall Mean Change From Baseline in Mean Number of Nighttime Voids at Week 12 — -2.01 Number of nocturnal voids
Migraine Disorders
Primary: Mean Number of Triptan Tablets Per Participant in 6-month Follow-up Period: Treatment-naïve Analysis — 17.7; 18.4; 19.2; 21.5 tablets per participant — p=<0.001
Anesthesia
Primary: Time to Recovery of the T4/T1 Ratio to 0.9. — 205; 112 seconds
Diabetes Mellitus, Type 2
Primary: Baseline and Change From Baseline in Hemoglobin A1c (A1C) at Week 24 — 8.08; 8.07; 7.98; 8.06 percentage of glycosylated hemoglobins — p=<.0001
Contact Lens Solutions
Primary: Slit-lamp Findings > Grade 2 — 3; 4; 3 participants
Age-related Macular Degeneration
Primary: Height (Amplitude) of Multifocal ERG Signal — 2.859 nanovolt/degree^2 — p=<0.05
Hormone Replacement Therapy
Primary: Mean Change From Baseline in the Number of Moderate to Severe Hot Flushes, Week 4, ITT (Intention to Treat) Population — -54.1; -62.0; -54.5 Change in Hot Flush Count
Pulmonary Disease, Chronic Obstructive
Primary: Time to First Chronic Obstructive Pulmonary Disease (COPD) Event — 325.17; 315.89; 321.59; 330.24 days
Rheumatoid Arthritis
Primary: Synovial Blood Flow — 9.48; 10.55; 8.31; 9.78 pixel count
Tobacco Dependence
Primary: Maximum Observed Plasma Concentration (Cmax) — 3.90; 4.00; 4.08 ng/mL
Diabetes Mellitus, Type 2
Primary: AUC0-t of Rosiglitazone Maleate — 1731.22; 1770.93 ng per hour per ml (ng.h/ml)
Liver Transplantation
Primary: Mean Change From Baseline in Cockcroft-Gault Calculated Creatinine Clearance (CrCl) — 0.99; 2.26 mL/min